Related to Partnership Will Develop Five Antibody-Based Anticancer Drugs

• 
• Sequencing Assays
• Roche
• GS GType TET2/CBL/KRAS and the GS GType RUNX1 primer sets are designed for comprehensive genetic variation detection in four key human genes using the 454 GS Junior and GS FLX Systems. The sequence-based assays offer a solution for cancer researche
• 
• Tumor Marker Control
• Randox Laboratories
• The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
• 
• Mouse Monoclonal IgM Antibody
• ANP Technologies
• ANPEG-1 is a mouse monoclonal IgM antibody developed using a linear 40 kDa PEG polymer immunogen. It has been used as a positive control antibody in double-bridging immunogenicity assays in both ELISA and LFA formats. ANPEG-1 can be used as either
• 
• Monoclonal Antibodies
• Beckman Coulter
• Fourteen new human monoclonal antibodies are now available through a partnership with Trillium Diagnostics including human anti-hemoglobin F, which recognizes fetal hemoglobin molecules; CD163 markers for anti-inflammatory signal and disease resear
• 
• HCP Antibodies
• Rockland Immunochemicals
• Host-cell protein (HCP) antibodies that detect high, medium, and low-molecular weight proteins are now available. Host-cell proteins are process-related impurities derived from a host-cell expression system that may be present in trace amounts in a
• 
• Monoclonal Antibodies
• Trevigen
• XPF/ERCC1 forms a heterodimer complex and catalyzes 5’ incision to the DNA damage during nucleotide excision repair. ERCC1/XPF is also required for repair of DNA interstrand crosslinks and involved in repair of double-strand breaks. A monoclonal XP
• 
• Antibody Microarray Kit
• Kinexus
• The Kinex™ 850-antibody microarray tracks the levels and functional states of many diverse proteins in human and animal cell and tissue specimens and features more than 330 phosphosite and 540 pan-specific antibody probes. This can provide research
• 
• Knockout Cell Lines for Cancer Research
• Cellectis bioresearch
• The cells in CanCELL™ cell lines represent comprehensive knockouts of major disease-relevant oncogenes and tumor suppressor genes. CanCELL cell lines are generated using TALEN™ technology and offer opportunities to study signaling pathways and gene
• 
• Transfection Reagent
• Mirus Bio
• TransIT®-BrCa transfection reagent is a dedicated breast cancer cell-line specific reagent that can help researchers achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D. It c
• 
• DNA Reference Standard
• Horizon Discovery
• The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds
• 
• Antibody Arrays
• R&D Systems
• With Proteome Profiler Antibody Arrays, instead of performing multiple Western blots, users can start their experiments by profiling their lysates for up to 59 phospho-proteins in a single sample. Proteome Profiler Antibody Arrays can reveal relati